AVTX Return on Tangible Equity | AVALO THERAPEUTICS, INC.

AVALO THERAPEUTICS, INC. (AVTX) Return on Tangible Equity

2026-06-30: Return Tang Equity -22.90%.
2026-03-31: Return Tang Equity -146.56%.
2025-12-31: Return Tang Equity -107.87%.
2025-09-30: Return Tang Equity -123.24%.

Complete source-backed return tang equity history.

Available history: 2013-12-31 to 2026-06-30
Data captured: 2026-09-04

Historical Return Tang Equity

Date	Return Tang Equity
2026-06-30	-22.90%
2026-03-31	-146.56%
2025-12-31	-107.87%
2025-09-30	-123.24%
2025-06-30	-49.13%
2025-03-31	65.12%
2024-12-31	-28.67%
2024-09-30	-75.26%
2024-06-30	150.24%
2024-03-31	116.12%
2023-12-31	986.37%
2023-09-30	-11604.20%
2023-06-30	115.86%
2023-03-31	142.98%
2022-12-31	164.50%
2022-09-30	309.81%
2022-06-30	351.16%
2022-03-31	934.57%
2021-12-31	-977.14%
2021-09-30	-332.40%
2021-06-30	-1374.45%
2021-03-31	-425.75%
2020-12-31	-741.13%
2020-09-30	-212.76%
2020-06-30	-109.04%
2020-03-31	-339.73%
2019-12-31	-386.30%
2019-09-30	1189.32%
2019-06-30	1767.64%
2019-03-31	-1481.72%
2018-12-31	-1465.31%
2018-09-30	258.01%
2018-06-30	-34.75%
2018-03-31	-84.59%
2017-12-31	-566.55%
2017-09-30	60.23%
2017-06-30	-368.89%
2017-03-31	3122.01%
2016-12-31	-7957.22%
2016-09-30	-3149.39%
2016-06-30	-233.42%
2016-03-31	-139.54%
2015-12-31	-80.18%
2015-09-30	28.51%

Annual Return Tang Equity

Date	Return Tang Equity
2025-12-31	-107.87%
2024-12-31	-28.67%
2023-12-31	986.37%
2022-12-31	164.50%
2021-12-31	-977.14%
2020-12-31	-741.13%
2019-12-31	-386.30%
2018-12-31	-1465.31%
2017-12-31	-566.55%
2016-12-31	-7957.22%
2015-12-31	-80.18%
2014-12-31	60.98%
2013-12-31	73.09%

Similar stocks

Stock Name	Country	Market Cap	PE Ratio
Immix Biopharma, Inc. (IMMX)	United States	$0.837B	-18.44
Obsidian Therapeutics, Inc. (OBX)	United States	$0.829B
ARDELYX, INC. (ARDX)	United States	$0.857B	-22.86
LEXICON PHARMACEUTICALS, INC. (LXRX)	United States	$0.823B	-17.48
GYRE THERAPEUTICS, INC. (GYRE)	United States	$0.818B	-24.71
GERON CORP (GERN)	United States	$0.803B	-12.14
Cryoport, Inc. (CYRX)	United States	$0.881B	-21.29
Theravance Biopharma, Inc. (TBPH)		$0.885B	16.40
Aclaris Therapeutics, Inc. (ACRS)	United States	$0.792B	-9.78
RIGEL PHARMACEUTICALS INC (RIGL)	United States	$0.893B	2.25